Vir Biotechnology
IPO
- Headquarters
- San Francisco, California
- Employees
- 201–500
- Founded
- 2016
- Business Model
- B2B
- Website
- vir.bio
- Total Funding
- $250.0M
- Last Round
- $250.0M Growth EquityOct 2024
About
Clinical-stage biotech developing antibody- and T-cell engager-based therapeutics for infectious diseases and cancer.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account